Human Immunoglobulin (pH4) is Driving the Future of IVIg Therapy

added blog Health

2025-12-08 12:21:29 -

In the complex landscape of immunotherapy, a critical blood product stands out: Human Immunoglobulin (pH4) for Intravenous Injection (IVIg). Used to treat a wide array of serious conditions—from primary immunodeficiency diseases (PIDD) to autoimmune disorders—this life-saving therapy is not just essential; it is currently fueling a healthcare market surge. A recent industry...

0 Comments 0 Shares 700 Views 0 Reviews